Condition
Structural Valve Deterioration
Total Trials
4
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Recruiting2
Unknown1
Not Yet Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07885761Not Yet Recruiting
REVIVE-FR Registry
NCT05601453RecruitingPrimary
The ReTAVI Prospective Observational Registry
NCT06049654Not ApplicableRecruiting
Comparison of Allegra vs Sapien Transcatheter Aortic Valves in Valve-In-Valve Indication
NCT05836311Unknown
Single Perclose Escalation Technique for Vascular Closure in TAVR
Showing all 4 trials